Sökresultat - James J. Ferguson

  • Visas 1 - 16 av 16 resultat
Förfina resultatet
  1. 1
    Protein Synthesis and Adrenocorticotropin Responsiveness

    Protein Synthesis and Adrenocorticotropin Responsiveness av James J. Ferguson

    Publicerad 1963
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  2. 2
    Photoaffinity Labeling with Cyclic Nucleotides

    Photoaffinity Labeling with Cyclic Nucleotides av Ross S. Antonoff, James J. Ferguson

    Publicerad 1974
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  3. 3
    Comparison of Hemochron and HemoTec activated coagulation time target values during percutaneous transluminal coronary angioplasty

    Comparison of Hemochron and HemoTec activated coagulation time target values during percutaneous transluminal coronary angioplasty av Amilcar Avendan̄o, James J. Ferguson

    Publicerad 1994
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  4. 4
    The Biosynthesis of β-Hydroxy-β-methylglutaryl Coenzyme A in Yeast

    The Biosynthesis of β-Hydroxy-β-methylglutaryl Coenzyme A in Yeast av Harry Rudney, James J. Ferguson

    Publicerad 1959
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  5. 5
    Yeast Malate Dehydrogenase: Enzyme Inactivation in Catabolite Repression

    Yeast Malate Dehydrogenase: Enzyme Inactivation in Catabolite Repression av James J. Ferguson, Matthias Boll, Helmut Holzer

    Publicerad 1967
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  6. 6
    THE BIOSYNTHESIS OF MEVALONIC ACID

    THE BIOSYNTHESIS OF MEVALONIC ACID av James J. Ferguson, I.F. Durr, Harry Rudney

    Publicerad 1959
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  7. 7
    The relationships of high energy phosphates, tissue pH, and regional blood flow to diastolic distensibility in the ischemic dog myocardium.

    The relationships of high energy phosphates, tissue pH, and regional blood flow to diastolic distensibility in the ischemic dog myocardium. av Shin‐ichi Momomura, Joanne S. Ingwall, J. Anthony Parker, Peter Sahagian, James J. Ferguson, William Grossman

    Publicerad 1985
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  8. 8
    Bleeding risks of combination vs. single antiplatelet therapy: a meta‐analysis of 18 randomized trials comprising 129 314 patients

    Bleeding risks of combination vs. single antiplatelet therapy: a meta‐analysis of 18 randomized trials comprising 129 314 patients av Victor L. Serebruany, Alex I. Malinin, James J. Ferguson, Javad Vahabi, Dan Atar, Charles H. Hennekens

    Publicerad 2008
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  9. 9
    Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries.

    Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries. av S K Yao, J C Ober, Ashok Krishnaswami, James J. Ferguson, H. Vernon Anderson, Paolo Golino, L. Maximilian Buja, J. T. Willerson

    Publicerad 1992
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  10. 10
    Trends in intraaortic balloon counterpulsation complications and outcomes in cardiac surgery

    Trends in intraaortic balloon counterpulsation complications and outcomes in cardiac surgery av Jan T. Christenson, Marc Cohen, James J. Ferguson, Robert J. Freedman, Michael F. Miller, E. Magnus Ohman, Ramachandra C. Reddy, Gregg W. Stone, Philip Urban

    Publicerad 2002
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  11. 11
    Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty.

    Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty. av Eric J. Topol, R Bonan, D E Jewitt, Ulrich Sigwart, V V Kakkar, Martin T. Rothman, David de Bono, James J. Ferguson, J T Willerson, John Strony

    Publicerad 1993
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  12. 12
    Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention

    Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention av Keaven M. Anderson, Robert M. Califf, Gregg W. Stone, Franz-Josef Neumann, Gilles Montalescot, Dave P. Miller, James J. Ferguson, James T. Willerson, Harlan F. Weisman, Eric J. Topol

    Publicerad 2001
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  13. 13
    Pharmacodynamic Efficacy, Clinical Safety, and Outcomes After Prolonged Platelet Glycoprotein IIb/IIIa Receptor Blockade With Oral Xemilofiban

    Pharmacodynamic Efficacy, Clinical Safety, and Outcomes After Prolonged Platelet Glycoprotein IIb/IIIa Receptor Blockade With Oral Xemilofiban av Dean J. Kereiakes, Neal S. Kleiman, James J. Ferguson, A.R. Zaki Masud, Thomas M. Broderick, Charles W. Abbottsmith, John Paul Runyon, Linda C. Anderson, Robert J. Anders, Roger J. Dreiling, Gary Hantsbarger, Brian Bryzinski, Eric J. Topol

    Publicerad 1998
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  14. 14
    Randomized, Double-Blind, Placebo-Controlled, International Trial of the Oral IIb/IIIa Antagonist Lotrafiban in Coronary and Cerebrovascular Disease

    Randomized, Double-Blind, Placebo-Controlled, International Trial of the Oral IIb/IIIa Antagonist Lotrafiban in Coronary and Cerebrovascular Disease av Eric J. Topol, Donald Easton, Robert A. Harrington, Pierre Amarenco, Robert M. Califf, Carmen Graffagnino, Stephen M. Davis, H.C. Diener, James J. Ferguson, Desmond J. Fitzgerald, Jeffrey R. Granett, Ashfaq Shuaib, Peter J. Koudstaal, Pierre Théroux, Frans Van de Werf, Kristina N. Sigmon, Karen S. Pieper, Marc Vallée, James T. Willerson

    Publicerad 2003
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  15. 15
    Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) Trial

    Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) Trial av David R. Holmes, Michael P. Savage, J M Lablanche, Lars Grip, P. W. Serruys, Peter J. Fitzgerald, David L. Fischman, Sheldon Goldberg, Jeffrey Brinker, Andreas M. Zeiher, Leonard M. Shapiro, James T. Willerson, Barry R. Davis, James J. Ferguson, Jeffrey J. Popma, Spencer B. King, A. Michael Lincoff, James E. Tcheng, Robert Chan, Jeffrey R. Granett, Marcia Poland

    Publicerad 2002
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  16. 16
    Enoxaparin vs Unfractionated Heparin in High-Risk Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Managed With an Intended Early Invasive Strategy

    Enoxaparin vs Unfractionated Heparin in High-Risk Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Managed With an Intended Early Invasive Strategy av James J Ferguson, Robert M. Califf, Elliott M. Antman, Marc Cohen, Cindy L. Grines, Shaun Goodman, Dean J. Kereiakes, Anatoly Langer, Kenneth W. Mahaffey, Christopher C. Nessel, Paul W. Armstrong, Álvaro Avezum, Philip E. Aylward, Richard C. Becker, Luigi M. Biasucci, Steven Borzak, Jacques Col, M Frey, E Fry, Dietrich C. Gulba, Sema Güneri, Enrique Gurfinkel, Robert A. Harrington, Judith S. Hochman, Neal S. Kleiman, Martin B. Leon, José Luis López-Sendón, Carl J. Pepine, Witold Rużyłło, Steven R. Steinhubl, Paul S. Teirstein, Luis O. Toro-Figueroa, Harvey D. White

    Publicerad 2004
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:

Sökverktyg: